{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:50:47Z","timestamp":1791888647415,"version":"4.3.4"},"reference-count":145,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.cca.2017.09.007","type":"journal-article","created":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T13:45:16Z","timestamp":1505137516000},"page":"44-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Heart-type fatty acid-binding protein in cardiovascular disease: A systemic review"],"prefix":"10.1016","volume":"474","author":[{"given":"Yoichiro","family":"Otaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4565-3799","authenticated-orcid":false,"given":"Tetsu","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4043","key":"10.1016\/j.cca.2017.09.007_bb0005","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.177.4043.56","article-title":"A binding protein for fatty acids in cytosol of intestinal mucosa, liver, myocardium, and other tissues","volume":"177","author":"Ockner","year":"1972","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.cca.2017.09.007_bb0010","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/0006-291X(72)90931-X","article-title":"The binding of fatty acids to cytoplasmic proteins: binding to Z protein in liver and other tissues of the rat","volume":"47","author":"Mishkin","year":"1972","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.cca.2017.09.007_bb0015","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ygeno.2008.08.003","article-title":"A novel fatty acid-binding protein (FABP) gene resulting from tandem gene duplication in mammals: transcription in rat retina and testis","volume":"92","author":"Liu","year":"2008","journal-title":"Genomics"},{"issue":"1","key":"10.1016\/j.cca.2017.09.007_bb0020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1388-1981(00)00046-9","article-title":"The fatty acid transport function of fatty acid-binding proteins","volume":"1486","author":"Storch","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"issue":"1\u20132","key":"10.1016\/j.cca.2017.09.007_bb0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0009-3084(85)90061-1","article-title":"Fatty acid binding proteins from heart","volume":"38","author":"Glatz","year":"1985","journal-title":"Chem. Phys. Lipids"},{"issue":"1\u20132","key":"10.1016\/j.cca.2017.09.007_bb0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cccn.2004.09.001","article-title":"Fatty acid-binding proteins as plasma markers of tissue injury","volume":"352","author":"Pelsers","year":"2005","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.cca.2017.09.007_bb0035","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1043-2760(00)00257-5","article-title":"The mammalian fatty acid-binding protein multigene family: molecular and genetic insights into function","volume":"11","author":"Hertzel","year":"2000","journal-title":"Trends Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.cca.2017.09.007_bb0040","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/1753-0407.12496","article-title":"Intestinal fatty acid binding protein Ala54Thr polymorphism is associated with peripheral atherosclerosis combined with type 2 diabetes mellitus","volume":"9","author":"Khattab","year":"2017","journal-title":"J. Diabetes"},{"issue":"3","key":"10.1016\/j.cca.2017.09.007_bb0045","doi-asserted-by":"crossref","first-page":"R173","DOI":"10.1530\/JOE-17-0031","article-title":"Role of the fatty acid-binding protein 4 in heart failure and cardiovascular disease","volume":"233","author":"Rodriguez-Calvo","year":"2017","journal-title":"J. Endocrinol."},{"issue":"17","key":"10.1016\/j.cca.2017.09.007_bb0050","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1093\/eurheartj\/ehn295","article-title":"Epidermal fatty-acid-binding protein: a new circulating biomarker associated with cardio-metabolic risk factors and carotid atherosclerosis","volume":"29","author":"Yeung","year":"2008","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.cca.2017.09.007_bb0055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00041433-200204000-00005","article-title":"Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis","volume":"13","author":"Boord","year":"2002","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.cca.2017.09.007_bb0060","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neures.2014.02.003","article-title":"Preservation of cochlear function in Fabp3 (H-Fabp) knockout mice","volume":"81\u201382","author":"Suzuki","year":"2014","journal-title":"Neurosci. Res."},{"issue":"8","key":"10.1016\/j.cca.2017.09.007_bb0065","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1523\/JNEUROSCI.4140-09.2010","article-title":"Heart-type fatty acid binding protein regulates dopamine D2 receptor function in mouse brain","volume":"30","author":"Shioda","year":"2010","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.cca.2017.09.007_bb0070","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1365-2443.2011.01517.x","article-title":"Fatty acid-binding protein 3 stimulates glucose uptake by facilitating AS160 phosphorylation in mouse muscle cells","volume":"16","author":"Kusudo","year":"2011","journal-title":"Genes Cells"},{"issue":"2","key":"10.1016\/j.cca.2017.09.007_bb0075","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.bbrc.2008.10.041","article-title":"Induction of fatty acid-binding protein 3 in brown adipose tissue correlates with increased demand for adaptive thermogenesis in rodents","volume":"377","author":"Yamashita","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.cca.2017.09.007_bb0080","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF01454012","article-title":"Histochemical localization of heart-type fatty-acid binding protein in human and murine tissues","volume":"103","author":"Zschiesche","year":"1995","journal-title":"Histochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.cca.2017.09.007_bb0085","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0005-2760(88)90141-5","article-title":"Release of fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox","volume":"961","author":"Glatz","year":"1988","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.cca.2017.09.007_bb0090","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/ajh.2008.40","article-title":"Association between fatty acid binding protein 3 gene variants and essential hypertension in humans","volume":"21","author":"Ueno","year":"2008","journal-title":"Am. J. Hypertens."},{"issue":"33","key":"10.1016\/j.cca.2017.09.007_bb0095","doi-asserted-by":"crossref","first-page":"34481","DOI":"10.1074\/jbc.M314263200","article-title":"Heart fatty acid uptake is decreased in heart fatty acid-binding protein gene-ablated mice","volume":"279","author":"Murphy","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.cca.2017.09.007_bb0100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1161\/01.RES.85.4.329","article-title":"Impaired long-chain fatty acid utilization by cardiac myocytes isolated from mice lacking the heart-type fatty acid binding protein gene","volume":"85","author":"Schaap","year":"1999","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.cca.2017.09.007_bb0105","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1161\/CIRCULATIONAHA.107.181940","volume":"116","author":"Anderson","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cca.2017.09.007_bb0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.forsciint.2005.08.008","article-title":"Heart fatty acid binding protein as a marker for postmortem detection of early myocardial damage","volume":"160","author":"Meng","year":"2006","journal-title":"Forensic Sci. Int."},{"issue":"23","key":"10.1016\/j.cca.2017.09.007_bb0115","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1016\/j.jacc.2009.12.062","article-title":"Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative","volume":"55","author":"Viswanathan","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.cca.2017.09.007_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2009.08.645","article-title":"Comparison of usefulness of heart-type fatty acid binding protein versus cardiac troponin T for diagnosis of acute myocardial infarction","volume":"105","author":"Haltern","year":"2010","journal-title":"Am. J. Cardiol."},{"issue":"5","key":"10.1016\/j.cca.2017.09.007_bb0125","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00380-006-0908-2","article-title":"The use of human heart-type fatty acid-binding protein as an early diagnostic biochemical marker of myocardial necrosis in patients with acute coronary syndrome, and its comparison with troponin-T and creatine kinase-myocardial band","volume":"21","author":"Ruzgar","year":"2006","journal-title":"Heart Vessel."},{"issue":"2","key":"10.1016\/j.cca.2017.09.007_bb0130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0009-8981(98)00012-6","article-title":"Thrombolytic therapy does not change the release ratios of enzymatic and non-enzymatic myocardial marker proteins","volume":"272","author":"Wodzig","year":"1998","journal-title":"Clin. Chim. Acta"},{"issue":"8","key":"10.1016\/j.cca.2017.09.007_bb0135","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/heartjnl-2013-305253","article-title":"Release kinetics of early ischaemic biomarkers in a clinical model of acute myocardial infarction","volume":"100","author":"Liebetrau","year":"2014","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.cca.2017.09.007_bb0140","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1515\/CCLM.2000.034","volume":"38","author":"Okamoto","year":"2000","journal-title":"Clin. Chem. Lab. Med."},{"issue":"3","key":"10.1016\/j.cca.2017.09.007_bb0145","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0002-9343(03)00325-5","article-title":"Use of a whole blood rapid panel test for heart-type fatty acid-binding protein in patients with acute chest pain: comparison with rapid troponin T and myoglobin tests","volume":"115","author":"Seino","year":"2003","journal-title":"Am. J. Med."},{"issue":"23","key":"10.1016\/j.cca.2017.09.007_bb0150","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1093\/eurheartj\/ehn363","article-title":"Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T","volume":"29","author":"McCann","year":"2008","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.cca.2017.09.007_bb0155","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/AC.66.3.2114131","article-title":"Diagnostic and prognostic value of heart-type fatty acid-binding protein in the early hours of acute myocardial infarction","volume":"66","author":"Garcia-Valdecasas","year":"2011","journal-title":"Acta Cardiol."},{"issue":"1","key":"10.1016\/j.cca.2017.09.007_bb0160","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/jcla.20276","article-title":"Prognostic value of combination of heart-type fatty acid-binding protein and ischemia-modified albumin in patients with acute coronary syndromes and normal troponin T values","volume":"23","author":"Liyan","year":"2009","journal-title":"J. Clin. Lab. Anal."},{"issue":"4","key":"10.1016\/j.cca.2017.09.007_bb0165","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/emermed-2012-201174","article-title":"Heart-type fatty acid binding protein as an early marker for myocardial infarction: systematic review and meta-analysis","volume":"30","author":"Carroll","year":"2013","journal-title":"Emerg. Med. J."},{"issue":"24","key":"10.1016\/j.cca.2017.09.007_bb0170","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1136\/hrt.2010.208272","article-title":"Heart-type fatty acid-binding protein in the early diagnosis of acute myocardial infarction: a systematic review and meta-analysis","volume":"96","author":"Bruins Slot","year":"2010","journal-title":"Heart"},{"issue":"1\u20132","key":"10.1016\/j.cca.2017.09.007_bb0175","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clinbiochem.2012.10.016","article-title":"Critical review and meta-analysis on the combination of heart-type fatty acid binding protein (H-FABP) and troponin for early diagnosis of acute myocardial infarction","volume":"46","author":"Lippi","year":"2013","journal-title":"Clin. Biochem."},{"issue":"6","key":"10.1016\/j.cca.2017.09.007_bb0180","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.1016\/j.ijcard.2013.08.002","article-title":"Point-of-care tests in suspected acute myocardial infarction: a systematic review","volume":"168","author":"Bruins Slot","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"9","key":"10.1016\/j.cca.2017.09.007_bb0185","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1056\/NEJMoa0900428","article-title":"Early diagnosis of myocardial infarction with sensitive cardiac troponin assays","volume":"361","author":"Reichlin","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.cca.2017.09.007_bb0190","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/2048872615570221","article-title":"Point-of-care heart-type fatty acid binding protein versus high-sensitivity troponin T testing in emergency patients at high risk for acute coronary syndrome","volume":"5","author":"Kellens","year":"2016","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"issue":"2","key":"10.1016\/j.cca.2017.09.007_bb0195","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ijcard.2011.10.080","article-title":"Comparison of heart-type fatty acid binding protein and sensitive troponin for the diagnosis of early acute myocardial infarction","volume":"166","author":"Kagawa","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"Pt 3","key":"10.1016\/j.cca.2017.09.007_bb0200","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/0004563214553277","article-title":"Heart-type fatty acid binding protein in early diagnosis of myocardial infarction in the era of high-sensitivity troponin: a systematic review and meta-analysis","volume":"52","author":"Liou","year":"2015","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2017.09.007_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.hlc.2017.03.165","article-title":"Early diagnostic performance of heart-type fatty acid binding protein in suspected acute myocardial infarction: evidence from a meta-analysis of contemporary studies","author":"Xu","year":"2017","journal-title":"Heart Lung Circ."},{"issue":"3","key":"10.1016\/j.cca.2017.09.007_bb0210","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/13814780903329528","article-title":"Chest pain in primary care: epidemiology and pre-work-up probabilities","volume":"15","author":"Bosner","year":"2009","journal-title":"Eur. J. Gen. Pract."},{"issue":"490","key":"10.1016\/j.cca.2017.09.007_bb0215","first-page":"378","article-title":"Chest pain and ischaemic heart disease in primary care","volume":"53","author":"Nilsson","year":"2003","journal-title":"Br. J. Gen. Pract."},{"issue":"1","key":"10.1016\/j.cca.2017.09.007_bb0220","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12873-016-0089-y","article-title":"Heart fatty acid binding protein and cardiac troponin: development of an optimal rule-out strategy for acute myocardial infarction","volume":"16","author":"Young","year":"2016","journal-title":"BMC Emerg. Med."},{"issue":"3","key":"10.1016\/j.cca.2017.09.007_bb0225","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3109\/13814788.2015.1013934","article-title":"Heart-type fatty acid binding protein (H-FABP) in patients in an emergency department setting, suspected of acute coronary syndrome: optimal cut-off point, diagnostic value and future opportunities in primary care","volume":"21","author":"Willemsen","year":"2015","journal-title":"Eur. J. Gen. Pract."},{"issue":"3","key":"10.1016\/j.cca.2017.09.007_bb0230","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ajem.2014.11.012","article-title":"Performances of the heart fatty acid protein assay for the rapid diagnosis of acute myocardial infarction in ED patients","volume":"33","author":"Dupuy","year":"2015","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.cca.2017.09.007_bb0235","first-page":"1","article-title":"Heart-type fatty acid binding protein is a sensitive biomarker for early AMI detection in troponin negative patients: a pilot study","author":"Agnello","year":"2017","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"1","key":"10.1016\/j.cca.2017.09.007_bb0240","first-page":"67","article-title":"Polymorphisms of the heart-type fatty acid-binding protein as a prognostic factor in patients with atherosclerosis","volume":"44","author":"Kim","year":"2014","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.cca.2017.09.007_bb0245","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.fob.2014.10.014","article-title":"Heart-type fatty-acid-binding protein (FABP3) is a lysophosphatidic acid-binding protein in human coronary artery endothelial cells","volume":"4","author":"Tsukahara","year":"2014","journal-title":"FEBS Open Bio"},{"issue":"1\u20132","key":"10.1016\/j.cca.2017.09.007_bb0250","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000446652","article-title":"Increment of HFABP level in coronary artery in-stent restenosis segments in diabetic and nondiabetic minipigs: HFABP overexpression promotes multiple pathway-related inflammation, growth and migration in human vascular smooth muscle cells","volume":"53","author":"Chen","year":"2016","journal-title":"J. Vasc. Res."},{"issue":"10","key":"10.1016\/j.cca.2017.09.007_bb0255","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/heartjnl-2012-303325","article-title":"Heart-type fatty acid-binding protein in the early diagnosis of acute myocardial infarction","volume":"99","author":"Reiter","year":"2013","journal-title":"Heart"},{"issue":"21","key":"10.1016\/j.cca.2017.09.007_bb0260","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.jacc.2007.08.021","article-title":"Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values","volume":"50","author":"Kilcullen","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.cca.2017.09.007_bb0265","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCULATIONAHA.106.641936","article-title":"Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes","volume":"114","author":"O'Donoghue","year":"2006","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.cca.2017.09.007_bb0270","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1253\/circj.CJ-12-0999","article-title":"Elevated serum heart-type fatty acid-binding protein in the convalescent stage predicts long-term outcome in patients surviving acute myocardial infarction","volume":"77","author":"Matsumoto","year":"2013","journal-title":"Circ. J."},{"issue":"15","key":"10.1016\/j.cca.2017.09.007_bb0275","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/jama.2011.1474","article-title":"National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998\u20132008","volume":"306","author":"Chen","year":"2011","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.cca.2017.09.007_bb0280","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1161\/01.CIR.0000039105.49749.6F","article-title":"Lifetime risk for developing congestive heart failure: the Framingham heart study","volume":"106","author":"Lloyd-Jones","year":"2002","journal-title":"Circulation"},{"issue":"26","key":"10.1016\/j.cca.2017.09.007_bb0285","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJM197112232852601","article-title":"The natural history of congestive heart failure: the Framingham study","volume":"285","author":"McKee","year":"1971","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.cca.2017.09.007_bb0290","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0002-9343(02)01394-3","article-title":"Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure","volume":"113","author":"Setsuta","year":"2002","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.cca.2017.09.007_bb0295","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cardfail.2004.03.005","article-title":"Prognostic value of elevated circulating heart-type fatty acid binding protein in patients with congestive heart failure","volume":"11","author":"Arimoto","year":"2005","journal-title":"J. Card. Fail."},{"issue":"5","key":"10.1016\/j.cca.2017.09.007_bb0300","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0002-9149(99)00391-4","article-title":"Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure","volume":"84","author":"Setsuta","year":"1999","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.cca.2017.09.007_bb0305","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/01.CIR.103.3.369","article-title":"Persistently increased serum concentrations of cardiac troponin t in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes","volume":"103","author":"Sato","year":"2001","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.cca.2017.09.007_bb0310","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1161\/01.CIR.0000145158.33801.F3","article-title":"Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identification","volume":"110","author":"Perna","year":"2004","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.cca.2017.09.007_bb0315","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJM199704173361603","article-title":"Apoptosis in the failing human heart","volume":"336","author":"Olivetti","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.cca.2017.09.007_bb0320","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1161\/01.RES.0000067471.95890.5C","article-title":"Myocytes die by multiple mechanisms in failing human hearts","volume":"92","author":"Kostin","year":"2003","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.cca.2017.09.007_bb0325","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/oxfordjournals.eurheartj.a014834","article-title":"Cellular mechanisms of contractile dysfunction in human heart failure","volume":"17","author":"Davies","year":"1996","journal-title":"Eur. Heart J."},{"issue":"16","key":"10.1016\/j.cca.2017.09.007_bb0330","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM199610173351603","article-title":"Apoptosis in myocytes in end-stage heart failure","volume":"335","author":"Narula","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.cca.2017.09.007_bb0335","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1136\/heart.89.11.1303","article-title":"Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure","volume":"89","author":"Goto","year":"2003","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.cca.2017.09.007_bb0340","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jacc.2012.08.1003","article-title":"The circulating level of FABP3 is an indirect biomarker of microRNA-1","volume":"61","author":"Varrone","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.cca.2017.09.007_bb0345","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/CIRCRESAHA.113.300376","article-title":"Cardiac metabolism in heart failure: implications beyond ATP production","volume":"113","author":"Doenst","year":"2013","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.cca.2017.09.007_bb0350","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart\u2013an engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.cca.2017.09.007_bb0355","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1161\/01.CIR.94.11.2837","article-title":"Fatty acid oxidation enzyme gene expression is downregulated in the failing heart","volume":"94","author":"Sack","year":"1996","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.cca.2017.09.007_bb0360","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1096\/fasebj.13.8.805","article-title":"Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization","volume":"13","author":"Binas","year":"1999","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.cca.2017.09.007_bb0365","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1161\/CIRCRESAHA.109.200501","article-title":"Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease","volume":"105","author":"Lamounier-Zepter","year":"2009","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.cca.2017.09.007_bb0370","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1253\/circj.72.109","article-title":"Persistently increased serum concentration of heart-type fatty acid-binding protein predicts adverse clinical outcomes in patients with chronic heart failure","volume":"72","author":"Niizeki","year":"2008","journal-title":"Circ. J."},{"issue":"8","key":"10.1016\/j.cca.2017.09.007_bb0375","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1007\/s00246-015-1223-4","article-title":"Serum level of heart-type fatty acid binding protein (H-FABP) before and after treatment of congestive heart failure in children","volume":"36","author":"Zoair","year":"2015","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.cca.2017.09.007_bb0380","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/bs.acc.2016.09.002","article-title":"Novel biomarkers of heart failure","volume":"79","author":"Savic-Radojevic","year":"2017","journal-title":"Adv. Clin. Chem."},{"issue":"2","key":"10.1016\/j.cca.2017.09.007_bb0385","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ejheart.2006.05.014","article-title":"Systolic and diastolic heart failure: different phenotypes of the same disease?","volume":"9","author":"De Keulenaer","year":"2007","journal-title":"Eur. J. Heart Fail."},{"issue":"5","key":"10.1016\/j.cca.2017.09.007_bb0390","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"The SOLVD Investigators","year":"1991","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.cca.2017.09.007_bb0395","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1161\/01.CIR.91.10.2573","article-title":"Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy","volume":"91","author":"Greenberg","year":"1995","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.cca.2017.09.007_bb0400","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1161\/01.CIR.94.11.2807","article-title":"Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators","volume":"94","author":"Bristow","year":"1996","journal-title":"Circulation"},{"issue":"Suppl. 1","key":"10.1016\/j.cca.2017.09.007_bb0405","doi-asserted-by":"crossref","first-page":"SI19","DOI":"10.1016\/S0140-6736(98)90015-0","article-title":"Successes and failures of current treatment of heart failure","volume":"352","author":"Cleland","year":"1998","journal-title":"Lancet"},{"issue":"9386","key":"10.1016\/j.cca.2017.09.007_bb0410","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(03)14282-1","article-title":"Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-overall programme","volume":"362","author":"Pfeffer","year":"2003","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.cca.2017.09.007_bb0415","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jjcc.2012.06.006","article-title":"Ongoing myocardial damage in patients with heart failure and preserved ejection fraction","volume":"60","author":"Kutsuzawa","year":"2012","journal-title":"J. Cardiol."},{"issue":"9","key":"10.1016\/j.cca.2017.09.007_bb0420","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s12149-010-0409-3","article-title":"Iodine-123-metaiodobenzylguanidine imaging can predict future cardiac events in heart failure patients with preserved ejection fraction","volume":"24","author":"Katoh","year":"2010","journal-title":"Ann. Nucl. Med."},{"issue":"7","key":"10.1016\/j.cca.2017.09.007_bb0425","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/BF02985045","article-title":"Ongoing myocardial damage relates to cardiac sympathetic nervous disintegrity in patients with heart failure","volume":"19","author":"Arimoto","year":"2005","journal-title":"Ann. Nucl. Med."},{"issue":"5","key":"10.1016\/j.cca.2017.09.007_bb0430","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/FJC.0000000000000217","article-title":"Effect of carvedilol on serum heart-type fatty acid-binding protein, brain natriuretic peptide, and cardiac function in patients with chronic heart failure","volume":"65","author":"Sun","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.cca.2017.09.007_bb0435","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cardfail.2006.10.014","article-title":"Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients","volume":"13","author":"Niizeki","year":"2007","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.cca.2017.09.007_bb0440","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12872-015-0026-0","article-title":"Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I","volume":"15","author":"Hoffmann","year":"2015","journal-title":"BMC Cardiovasc. Disord."},{"issue":"8","key":"10.1016\/j.cca.2017.09.007_bb0445","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1253\/circj.69.922","article-title":"Combination of heart-type fatty acid binding protein and brain natriuretic peptide can reliably risk stratify patients hospitalized for chronic heart failure","volume":"69","author":"Niizeki","year":"2005","journal-title":"Circ. J."},{"issue":"11","key":"10.1016\/j.cca.2017.09.007_bb0450","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1253\/circj.CJ-08-0157","article-title":"Risk stratification of chronic heart failure patients by multiple biomarkers: implications of BNP, H-FABP, and PTX3","volume":"72","author":"Ishino","year":"2008","journal-title":"Circ. J."},{"issue":"7","key":"10.1016\/j.cca.2017.09.007_bb0455","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2169\/internalmedicine.53.1293","article-title":"Prognostic value of myocardial damage markers in patients with chronic heart failure with atrial fibrillation","volume":"53","author":"Otaki","year":"2014","journal-title":"Intern. Med."},{"issue":"9","key":"10.1016\/j.cca.2017.09.007_bb0460","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1253\/circj.71.1452","article-title":"Circulating levels of heart-type fatty acid-binding protein in a general Japanese population: effects of age, gender, and physiologic characteristics","volume":"71","author":"Niizeki","year":"2007","journal-title":"Circ. J."},{"issue":"2","key":"10.1016\/j.cca.2017.09.007_bb0465","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/eurheartj\/ehr269","article-title":"Suppression of persistent atrial fibrillation by genetic knockdown of caspase 3: a pre-clinical pilot study","volume":"34","author":"Trappe","year":"2013","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.cca.2017.09.007_bb0470","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.cardiores.2003.12.013","article-title":"Pathophysiological findings in a model of persistent atrial fibrillation and severe congestive heart failure","volume":"61","author":"Bauer","year":"2004","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.cca.2017.09.007_bb0475","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000319619","article-title":"Decreased apoptosis following successful ablation of atrial fibrillation","volume":"116","author":"Osmancik","year":"2010","journal-title":"Cardiology"},{"issue":"12","key":"10.1016\/j.cca.2017.09.007_bb0480","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1540-8167.2011.02123.x","article-title":"High washout rate of iodine-123-metaiodobenzylguanidine imaging predicts the outcome of catheter ablation of atrial fibrillation","volume":"22","author":"Arimoto","year":"2011","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"10","key":"10.1016\/j.cca.2017.09.007_bb0485","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa071098","article-title":"Prognostic importance of defibrillator shocks in patients with heart failure","volume":"359","author":"Poole","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.cca.2017.09.007_bb0490","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.clinbiochem.2011.05.029","article-title":"Heart-type fatty acid binding protein in elective cardioversion of atrial fibrillation","volume":"44","author":"Sbarouni","year":"2011","journal-title":"Clin. Biochem."},{"issue":"6","key":"10.1016\/j.cca.2017.09.007_bb0495","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/europace\/eup091","article-title":"Implantable cardioverter defibrillators and their role in heart failure progression","volume":"11","author":"Cevik","year":"2009","journal-title":"Europace"},{"issue":"6","key":"10.1016\/j.cca.2017.09.007_bb0500","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.joa.2016.03.007","article-title":"The association between defibrillation shock energy and acute cardiac damage in patients with implantable cardioverter defibrillators","volume":"32","author":"Ishigaki","year":"2016","journal-title":"J. Arrhythm."},{"issue":"3","key":"10.1016\/j.cca.2017.09.007_bb0505","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jjcc.2015.04.011","article-title":"Circulating heart-type fatty acid-binding protein levels predict ventricular fibrillation in Brugada syndrome","volume":"67","author":"Daidoji","year":"2016","journal-title":"J. Cardiol."},{"issue":"12","key":"10.1016\/j.cca.2017.09.007_bb0510","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1161\/CIRCULATIONAHA.105.167586","volume":"112","author":"Hunt","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.cca.2017.09.007_bb0515","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/01.CIR.96.2.509","article-title":"Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction","volume":"96","author":"Tsutamoto","year":"1997","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.cca.2017.09.007_bb0520","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jacc.2012.12.026","article-title":"Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease","volume":"61","author":"Omland","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.cca.2017.09.007_bb0525","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1161\/CIRCHEARTFAILURE.112.000075","article-title":"Outcomes and care of patients with acute heart failure syndromes and cardiac troponin elevation","volume":"6","author":"Braga","year":"2013","journal-title":"Circ. Heart Fail."},{"issue":"6","key":"10.1016\/j.cca.2017.09.007_bb0530","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrcardio.2012.37","article-title":"Novel biomarkers in chronic heart failure","volume":"9","author":"Ahmad","year":"2012","journal-title":"Nat. Rev. Cardiol."},{"issue":"18","key":"10.1016\/j.cca.2017.09.007_bb0535","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1093\/eurheartj\/ehn327","article-title":"Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects","volume":"29","author":"Eggers","year":"2008","journal-title":"Eur. Heart J."},{"issue":"22","key":"10.1016\/j.cca.2017.09.007_bb0540","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1001\/jama.2010.1768","article-title":"Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population","volume":"304","author":"de Lemos","year":"2010","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.cca.2017.09.007_bb0545","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1001\/jama.2010.1708","article-title":"Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults","volume":"304","author":"de Filippi","year":"2010","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.cca.2017.09.007_bb0550","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.jacc.2012.12.048","article-title":"Cardiac troponin I levels measured with a high-sensitive assay increase over time and are strong predictors of mortality in an elderly population","volume":"61","author":"Eggers","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.cca.2017.09.007_bb0555","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/hrt.82.3.265","article-title":"Mechanisms of progression in native coronary artery disease: role of healed plaque disruption","volume":"82","author":"Mann","year":"1999","journal-title":"Heart"},{"issue":"1 Pt 2","key":"10.1016\/j.cca.2017.09.007_bb0560","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1161\/01.HYP.35.1.360","article-title":"Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes","volume":"35","author":"Mervaala","year":"2000","journal-title":"Hypertension"},{"issue":"20","key":"10.1016\/j.cca.2017.09.007_bb0565","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1001\/jama.2012.14795","article-title":"Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fraction","volume":"308","author":"Hernandez","year":"2012","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.cca.2017.09.007_bb0570","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ijcard.2004.08.026","article-title":"Sympathetic activity and myocardial damage after stimulation of dorsal medulla and vagotomy in a novel animal model","volume":"100","author":"Chiu","year":"2005","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cca.2017.09.007_bb0575","doi-asserted-by":"crossref","first-page":"815098","DOI":"10.1155\/2012\/815098","article-title":"Impact of insulin resistance on silent and ongoing myocardial damage in normal subjects: the Takahata study","volume":"2012","author":"Narumi","year":"2012","journal-title":"Exp. Diabetes Res."},{"issue":"5","key":"10.1016\/j.cca.2017.09.007_bb0580","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094834","article-title":"Association of heart-type fatty acid-binding protein with cardiovascular risk factors and all-cause mortality in the general population: the Takahata study","volume":"9","author":"Otaki","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cca.2017.09.007_bb0585","first-page":"441","article-title":"Influence of age and sex and day-to-day and within-day biological variation on plasma concentrations of fatty acid-binding protein and myoglobin in healthy subjects","volume":"45","author":"Pelsers","year":"1999","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.cca.2017.09.007_bb0590","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1161\/01.RES.68.6.1560","article-title":"Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy","volume":"68","author":"Olivetti","year":"1991","journal-title":"Circ. Res."},{"issue":"1\u20132","key":"10.1016\/j.cca.2017.09.007_bb0595","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/A:1006878621126","article-title":"Fatty acid-binding proteins in the heart","volume":"180","author":"Schaap","year":"1998","journal-title":"Mol. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.cca.2017.09.007_bb0600","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.ijcard.2014.07.150","article-title":"Heart-type fatty acid-binding protein is a novel prognostic marker in patients with essential hypertension","volume":"176","author":"Setsuta","year":"2014","journal-title":"Int. J. Cardiol."},{"issue":"5","key":"10.1016\/j.cca.2017.09.007_bb0605","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2337\/diabetes.49.5.677","article-title":"Fuel selection in human skeletal muscle in insulin resistance: a reexamination","volume":"49","author":"Kelley","year":"2000","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.cca.2017.09.007_bb0610","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.2337\/diabetes.54.11.3133","article-title":"Partial gene deletion of heart-type fatty acid-binding protein limits the severity of dietary-induced insulin resistance","volume":"54","author":"Shearer","year":"2005","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.cca.2017.09.007_bb0615","article-title":"Heart-type fatty acid binding protein is associated with proteinuria in obesity","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cca.2017.09.007_bb0620","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ijcard.2014.08.007","article-title":"Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure","volume":"176","author":"Madamanchi","year":"2014","journal-title":"Int. J. Cardiol."},{"issue":"9","key":"10.1016\/j.cca.2017.09.007_bb0625","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1253\/circj.CJ-13-0971","article-title":"Epidemiology of heart failure in Asia","volume":"77","author":"Sakata","year":"2013","journal-title":"Circ. J."},{"issue":"1","key":"10.1016\/j.cca.2017.09.007_bb0630","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2010.165","article-title":"Epidemiology and risk profile of heart failure","volume":"8","author":"Bui","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"issue":"6","key":"10.1016\/j.cca.2017.09.007_bb0635","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/CIRCRESAHA.113.300268","article-title":"Epidemiology of heart failure","volume":"113","author":"Roger","year":"2013","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.cca.2017.09.007_bb0640","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/bjsm.32.2.121","article-title":"Early assessment of exercise induced skeletal muscle injury using plasma fatty acid binding protein","volume":"32","author":"Sorichter","year":"1998","journal-title":"Br. J. Sports Med."},{"issue":"2","key":"10.1016\/j.cca.2017.09.007_bb0645","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.300.2.197","article-title":"Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis","volume":"300","author":"Fowkes","year":"2008","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.cca.2017.09.007_bb0650","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ejvs.2006.04.005","article-title":"Prognostic significance of raised cardiac troponin T in patients presenting with acute limb ischaemia","volume":"32","author":"Rittoo","year":"2006","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"issue":"15","key":"10.1016\/j.cca.2017.09.007_bb0655","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.jacc.2013.05.059","article-title":"Elevated cardiac troponin T is associated with higher mortality and amputation rates in patients with peripheral arterial disease","volume":"63","author":"Linnemann","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2017.09.007_bb0660","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bbacli.2015.06.003","article-title":"Heart-type fatty acid binding protein and high-sensitivity troponin T are myocardial damage markers that could predict adverse clinical outcomes in patients with peripheral artery disease","volume":"4","author":"Otaki","year":"2015","journal-title":"BBA Clin."},{"issue":"9162","key":"10.1016\/j.cca.2017.09.007_bb0665","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0140-6736(98)07534-5","article-title":"Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)","volume":"353","author":"Goldhaber","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2017.09.007_bb0670","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jcrc.2016.05.014","article-title":"Heart-type fatty acid-binding protein and myocardial creatine kinase enable rapid risk stratification in normotensive patients with pulmonary embolism","volume":"35","author":"Langer","year":"2016","journal-title":"J. Crit. Care"},{"issue":"6","key":"10.1016\/j.cca.2017.09.007_bb0675","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1378\/chest.13-1008","article-title":"Prognostic value of plasma heart-type fatty acid-binding protein in patients with acute pulmonary embolism: a meta-analysis","volume":"146","author":"Ruan","year":"2014","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.cca.2017.09.007_bb0680","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jcrc.2015.05.026","article-title":"Risk stratification in acute pulmonary embolism with heart-type fatty acid-binding protein: a meta-analysis","volume":"30","author":"Bajaj","year":"2015","journal-title":"J. Crit. Care"},{"issue":"1","key":"10.1016\/j.cca.2017.09.007_bb0685","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.thromres.2014.10.007","article-title":"Prognostic role of heart-type fatty acid binding protein in pulmonary embolism: a meta-analysis","volume":"135","author":"Liu","year":"2015","journal-title":"Thromb. Res."},{"issue":"1\u20132","key":"10.1016\/j.cca.2017.09.007_bb0690","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cca.2006.02.032","article-title":"Plasma heart-type fatty acid binding protein is superior to troponin and myoglobin for rapid risk stratification in acute pulmonary embolism","volume":"371","author":"Kaczynska","year":"2006","journal-title":"Clin. Chim. Acta"},{"issue":"6","key":"10.1016\/j.cca.2017.09.007_bb0695","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.amjms.2016.08.018","article-title":"Heart-type fatty acid binding protein in the assessment of acute pulmonary embolism","volume":"352","author":"Qian","year":"2016","journal-title":"Am J Med Sci"},{"issue":"5","key":"10.1016\/j.cca.2017.09.007_bb0700","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1183\/09031936.00100407","article-title":"Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension","volume":"31","author":"Lankeit","year":"2008","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.cca.2017.09.007_bb0705","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1042\/CS20100014","article-title":"High-sensitive troponin T: a novel biomarker for prognosis and disease severity in patients with pulmonary arterial hypertension","volume":"119","author":"Filusch","year":"2010","journal-title":"Clin. Sci. (Lond.)"},{"issue":"3","key":"10.1016\/j.cca.2017.09.007_bb0710","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/0960327116646621","article-title":"Asymmetric dimethylarginine and heart-type fatty acid-binding protein 3 are risk markers of cardiotoxicity in carbon monoxide poisoning cases in Zagazig university hospitals","volume":"36","author":"Abass","year":"2017","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.cca.2017.09.007_bb0715","doi-asserted-by":"crossref","DOI":"10.1007\/s00424-017-1976-0","article-title":"Vasculo-protective effect of BMS-309403 is independent of its specific inhibition of fatty acid-binding protein 4","author":"Okamura","year":"2017","journal-title":"Pflugers Arch."},{"issue":"7","key":"10.1016\/j.cca.2017.09.007_bb0720","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1080\/13543776.2016.1182500","article-title":"Fatty acid binding protein (FABP) inhibitors: a patent review (2012-2015)","volume":"26","author":"Wang","year":"2016","journal-title":"Expert Opin. Ther. Pat."},{"issue":"3","key":"10.1016\/j.cca.2017.09.007_bb0725","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2174\/1573403X13666170116121451","article-title":"The prognostic value of heart type fatty acid binding protein in patients with suspected acute coronary syndrome: a systematic review","volume":"13","author":"Jones","year":"2017","journal-title":"Curr. Cardiol. Rev."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898117303534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898117303534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T05:45:07Z","timestamp":1570081507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898117303534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":145,"alternative-id":["S0009898117303534"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2017.09.007","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart-type fatty acid-binding protein in cardiovascular disease: A systemic review","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2017.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}